UPSC MainsMEDICAL-SCIENCE-PAPER-II202220 Marks
Q30.

Write the acute complications of Insulin dependent diabetes mellitus and outline their management.

How to Approach

This question requires a detailed understanding of the acute metabolic complications arising from insulin-dependent diabetes mellitus (IDDM), now more commonly referred to as Type 1 Diabetes. The answer should systematically outline each complication – Diabetic Ketoacidosis (DKA) and Hypoglycemia – detailing their pathophysiology, clinical presentation, diagnostic criteria, and comprehensive management protocols. A structured approach, covering definition, etiology, clinical features, diagnosis, and management for each complication, is crucial. Prioritize a clear and concise explanation of treatment algorithms, including fluid resuscitation, insulin therapy, electrolyte correction, and monitoring.

Model Answer

0 min read

Introduction

Insulin-dependent diabetes mellitus (Type 1 Diabetes) is characterized by the autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency. This necessitates exogenous insulin administration for survival. However, maintaining optimal glycemic control can be challenging, and acute metabolic disturbances are common and potentially life-threatening complications. The two primary acute complications are Diabetic Ketoacidosis (DKA) and Hypoglycemia. These conditions require prompt recognition and aggressive management to prevent significant morbidity and mortality. Understanding the underlying pathophysiology and implementing standardized treatment protocols are paramount in clinical practice.

Diabetic Ketoacidosis (DKA)

DKA results from a severe deficiency of insulin coupled with an excess of counter-regulatory hormones (glucagon, cortisol, growth hormone, epinephrine). This leads to hyperglycemia, lipolysis, and the production of ketone bodies.

Etiology:

  • Missed or inadequate insulin doses
  • Infection (pneumonia, urinary tract infection)
  • Illness or surgery
  • New onset Type 1 Diabetes

Clinical Features:

  • Hyperglycemia (blood glucose >250 mg/dL)
  • Ketosis (moderate to large ketones in urine or serum)
  • Metabolic acidosis (arterial pH <7.3, bicarbonate <15 mEq/L)
  • Dehydration
  • Kussmaul respirations (deep, rapid breathing)
  • Abdominal pain, nausea, vomiting
  • Altered mental status

Diagnosis:

Diagnosis is based on the triad of hyperglycemia, ketosis, and metabolic acidosis. Laboratory findings include elevated blood glucose, elevated serum ketones, low bicarbonate, and anion gap acidosis.

Management:

  • Fluid Resuscitation: Initial bolus of 0.9% saline followed by maintenance fluids based on hydration status.
  • Insulin Therapy: Continuous intravenous regular insulin infusion (typically 0.1 unit/kg/hour) until glucose levels fall to around 200-250 mg/dL.
  • Electrolyte Correction: Potassium is often depleted and requires careful replacement. Phosphate and magnesium may also need correction.
  • Monitoring: Frequent monitoring of blood glucose, electrolytes, arterial blood gases, and mental status.
  • Identify and Treat Precipitating Cause: Address underlying infection or illness.

Hypoglycemia

Hypoglycemia is defined as a blood glucose level below 70 mg/dL. It is a common complication of insulin therapy, resulting from an imbalance between insulin dose, carbohydrate intake, and physical activity.

Etiology:

  • Excessive insulin dose
  • Missed or delayed meals
  • Increased physical activity
  • Alcohol consumption
  • Impaired renal or hepatic function

Clinical Features:

Symptoms are categorized into autonomic (tremor, sweating, palpitations) and neuroglycopenic (confusion, dizziness, seizures, coma).

Diagnosis:

Diagnosis is based on plasma glucose levels (<70 mg/dL) and associated symptoms.

Management:

  • Mild Hypoglycemia (conscious, able to swallow): 15-20 grams of rapid-acting carbohydrates (glucose tablets, juice, regular soda). Recheck glucose after 15 minutes and repeat if necessary.
  • Severe Hypoglycemia (unconscious or unable to swallow): Glucagon injection (1 mg intramuscularly or subcutaneously) or intravenous dextrose (25-50 mL of 50% dextrose).
  • Prevention: Education on insulin adjustment, meal timing, and recognizing symptoms of hypoglycemia.
Complication DKA Hypoglycemia
Blood Glucose >250 mg/dL <70 mg/dL
Ketones Present (moderate to large) Absent
Arterial pH <7.3 Normal
Treatment Fluids, Insulin, Electrolytes Carbohydrates, Glucagon, Dextrose

Conclusion

Acute complications of insulin-dependent diabetes mellitus, namely DKA and hypoglycemia, represent significant clinical challenges. Effective management relies on prompt recognition, accurate diagnosis, and adherence to established treatment protocols. Patient education regarding self-management, insulin administration, and recognizing early warning signs is crucial for prevention. Continuous glucose monitoring (CGM) and insulin pump therapy are increasingly utilized to improve glycemic control and reduce the risk of these potentially life-threatening events. Further research into personalized diabetes management strategies is essential to optimize outcomes.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Ketogenesis
The metabolic process by which ketone bodies (acetoacetate, beta-hydroxybutyrate, and acetone) are produced from fatty acids in the liver, primarily during periods of prolonged fasting or carbohydrate deprivation.

Key Statistics

Approximately 1.6 million Americans are diagnosed with diabetes each year, with Type 1 diabetes accounting for 5-10% of all cases. (American Diabetes Association, 2023 - knowledge cutoff)

Source: American Diabetes Association

Hypoglycemia is estimated to occur in up to 40% of individuals with Type 1 diabetes annually. (Diabetes Care, 2015 - knowledge cutoff)

Source: Diabetes Care

Examples

DKA in a Young Athlete

A 16-year-old athlete with Type 1 diabetes presented with nausea, vomiting, and abdominal pain after a strenuous soccer practice. Blood glucose was 450 mg/dL, and urine ketones were positive. He was diagnosed with DKA and treated with intravenous fluids, insulin, and electrolyte correction, resulting in full recovery.

Frequently Asked Questions

What is the role of SGLT2 inhibitors in preventing DKA?

SGLT2 inhibitors can increase the risk of euglycemic DKA, a condition where DKA occurs despite relatively normal blood glucose levels. This is because they promote glucose excretion in the urine, potentially leading to ketone body accumulation. Caution is advised when using SGLT2 inhibitors, especially during illness or periods of reduced carbohydrate intake.

Topics Covered

MedicineEndocrinologyDiabetesComplicationsManagement